News
The “Top 10” list of best-selling gene therapies published by Genetic Engineering & Biotechnology News (GEN) in their May 2025 issue features three products based upon license agreements for technologies originating from the NIH Intramural Research Program. Featured and ranked on the GEN list are
The OTT is pleased to announce that the annual report for Fiscal Year 2013 is now available for downloading. Click the icon below to download and view the report.
NIH-OTT authors report in Nature Biotechnology (Jan 2014) an analysis of FDA approved drugs and biologics that utilize inventions licensed from the NIH Intramural Research Program (IRP). Compared with other public-sector research institutions in the US, the NIH-IRP contribution has had a
The Office of Intramural Research, Office of the Director, NIH, invites you to the eighth annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer. The lecture will be held on Friday, November 22, 2013, at 10:00 AM in the Lipsett Amphitheatre, Building 10, NIH